Literature DB >> 2365293

Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis.

K D Bentsen1, J H Henriksen, F Bendtsen, K Hørslev-Petersen, I Lorenzen.   

Abstract

Splanchnic and renal extraction of circulating aminoterminal propeptide of type III procollagen and related antigens were studied in 12 patients with normal liver function and in 19 patients with alcoholic cirrhosis during catheterization. Type III procollagen peptide in serum was measured in two assays: the Type III Procollagen Peptide Radioimmunoassay Kit, a new assay that selectively determines the intact propeptide (and larger type III propeptide-holding antigens) and the Type III procollagen Fab assay that measures both the intact propeptide and the smaller fragments that quantitatively dominate in serum. A significant decrease in the concentration of the intact propeptide between the artery and the hepatic vein was found in the group with normal liver function (p less than 0.01) and in patients with cirrhosis (p less than 0.01). In patients with cirrhosis, however, the splanchnic extraction ratio of the intact propeptide (median = 0.04, range = -0.03 to 0.16) was significantly lower than in patients with normal liver function (median = 0.17, range = 0.05 to 0.36, p less than 0.01). The concentration of the intact propeptide in the hepatic vein was positively correlated to hepatic pressure (n = 18, r = 0.51, p less than 0.05) and inversely correlated to indocyanine green clearance (n = 15, r = -0.61, p less than 0.05). No splanchnic extraction could be demonstrated in the Type III propeptide Fab assay. A significant renal extraction was found in the Fab assay, but not in Type III Procollagen Peptide Radioimmunoassay Kit.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2365293     DOI: 10.1002/hep.1840110608

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Markers of collagen and basement membrane metabolism in sera of patients with progressive systemic sclerosis.

Authors:  N G Guseva; N V Anikina; R Myllylä; L Risteli; J Risteli; J V Chochlova; K I Kivirikko; V A Nassonova
Journal:  Ann Rheum Dis       Date:  1991-07       Impact factor: 19.103

2.  Serum type IV collagen in various liver diseases in comparison with serum 7S collagen, laminin, and type III procollagen peptide.

Authors:  C Hirayama; H Suzuki; A Takada; K Fujisawa; K Tanikawa; S Igarashi
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

3.  Urine Collagen Fragments and CKD Progression-The Cardiovascular Health Study.

Authors:  Joachim H Ix; Mary L Biggs; Kenneth Mukamal; Luc Djousse; David Siscovick; Russell Tracy; Ronit Katz; Joseph A Delaney; Paulo Chaves; Dena E Rifkin; Jan M Hughes-Austin; Pranav S Garimella; Mark J Sarnak; Michael G Shlipak; Jorge R Kizer
Journal:  J Am Soc Nephrol       Date:  2015-02-05       Impact factor: 10.121

4.  Osteoporosis in lysinuric protein intolerance.

Authors:  K Parto; R Penttinen; I Paronen; L Pelliniemi; O Simell
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

5.  Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy.

Authors:  J Kjeldsen; O B Schaffalitzky de Muckadell; P Junker
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

6.  Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension.

Authors:  D J Leeming; M A Karsdal; I Byrjalsen; F Bendtsen; J Trebicka; M J Nielsen; C Christiansen; S Møller; A Krag
Journal:  Aliment Pharmacol Ther       Date:  2013-09-15       Impact factor: 8.171

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.